The effect of olpadronate in ovariectomized thyroxine-treated rats (Q36884731)

16 August 2017

title

The effect of olpadronate in ovariectomized thyroxine-treated rats (English)

1 reference

16 August 2017

Zeni S

1

1 reference

16 August 2017

Gomez-Acotto C

series ordinal

2

1 reference

16 August 2017

Mautalen C

series ordinal

3

1 reference

16 August 2017

publication date

1 October 1997

1 reference

16 August 2017

1 reference

16 August 2017

volume

21

1 reference

16 August 2017

issue

4

1 reference

16 August 2017

page(s)

329-333

1 reference

Sequential and precise in vivo measurement of bone mineral density in rats using dual-energy x-ray absorptiometry

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900146-4

7 January 2021

The aminobisphosphonate alendronate inhibits bone loss induced by thyroid hormone in the rat. Comparison between effects on tibiae and vertebrae

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900146-4

7 January 2021

Estrogens in the prevention and treatment of postmenopausal osteoporosis: a review

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900146-4

7 January 2021

Effects of amino-butylidene diphosphonate in hypercalcemia due to malignancy.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900146-4

7 January 2021

Bone mass in females with different thyroid disorders: influence of menopausal status

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900146-4

7 January 2021

Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900146-4

7 January 2021

Pathophysiological mechanisms of estrogen effect on bone metabolism. Dose-response relationships in early postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900146-4

7 January 2021

Trabecular bone remodeling and bone balance in hyperthyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900146-4

7 January 2021

The determination of total hydroxyproline in urine and bone extracts

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900146-4

7 January 2021

Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900146-4

7 January 2021

Differential action of pamidronate on trabecular and cortical bone in women with involutional osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900146-4

7 January 2021

Measurement of bone collagen degradation in hyperthyroidism and during thyroxine replacement therapy using pyridinium cross-links as specific urinary markers

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900146-4

7 January 2021

The binding of pyrophosphate and two diphosphonates by hydroxyapatite crystals

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900146-4

7 January 2021

The ovariectomized rat model of postmenopausal bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900146-4

7 January 2021

Skeletal response of ovariectomized rats to low and high doses of 17 beta-estradiol.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900146-4

7 January 2021

Age and menopause-related changes in indices of bone turnover

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900146-4

7 January 2021

Efficacy of the bisphosphonate APD in the control of Paget's bone disease

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900146-4

7 January 2021

Decreased parathyroid function in hyperthyroidism: interrelationships between serum parathyroid hormone, calcium-phosphorus metabolism and thyroid function

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900146-4

7 January 2021

A tetracycline-based histomorphometric evaluation of bone resorption and bone turnover in hyperthyroidism and hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900146-4

7 January 2021

Seasonal variations of 25 hydroxyvitamin D and parathyroid hormone in Ushuaia (Argentina), the southernmost city of the world

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900146-4

7 January 2021

Effect of Estrogens and Calcium Carbonate on Bone Loss in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900146-4

7 January 2021

Specificity of urinary excretion of cross-linked N-telopeptides of type I collagen as a marker of bone turnover.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900146-4

7 January 2021

Parenteral pamidronate prevents thyroid hormone-induced bone loss in rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900146-4

7 January 2021

The bisphosphonate alendronate (MK-217) inhibits bone loss due to ovariectomy in rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900146-4

7 January 2021

Bone loss and biochemical indices of bone remodeling in surgically induced postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900146-4

7 January 2021

The bisphosphonate, alendronate, prevents bone loss in ovariectomized baboons

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900146-4

7 January 2021

Aminohydroxybutane bisphosphonate inhibits bone loss due to immobilization in rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900146-4

7 January 2021

Maintained improvement in calcium balance and bone mineral content in patients with osteoporosis treated with the bisphosphonate APD

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900146-4

7 January 2021

Temporal relationship between bone loss and increased bone turnover in ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900146-4

7 January 2021

Estrogen Treatment Prevents Osteopenia and Depresses Bone Turnover in Ovariectomized Rats*

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900146-4

7 January 2021

Skeletal effects of withdrawal of estrogen and diphosphonate treatment in ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900146-4

7 January 2021

Skeletal alterations in ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900146-4

7 January 2021

Estrogen and diphosphonate treatment provide long-term protection against osteopenia in ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900146-4

7 January 2021

The effects of the aminobisphosphonate alendronate on thyroid hormone-induced osteopenia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900146-4

7 January 2021

The effect of 17 beta-estradiol treatment on the mass and the turnover of bone in ovariectomized rats taking a mild dose of thyroxin

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900146-4

7 January 2021

10.1016/S8756-3282(97)00146-4

Identifiers

DOI

1 reference

16 August 2017

1 reference